SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2802Jefferies Key Takeaway The Copaxone inequitable conduct trial kicked off yesterrkrw27/12/2011
2801Is it possible to win the E&Y award without being an Ernst & Young clienrkrw-6/21/2011
2800Do you feel that the discolsure of this paper is a "possibly bearish" Jeffry K. Smith-6/21/2011
2799<i>>If MNTA cannot overturn Teva's patents then it will be 2014 or DewDiligence_on_SI-6/20/2011
2798At the Goldman conference Wheeler had a good comment that may answer your questighmm-6/20/2011
2797Pre clinical research paper published... Momenta Pharmaceuticals Study Showing Ian@SI-6/20/2011
2796How realistic are the concerns below (posted by another poster)? >>>&gsemi_infinite -6/20/2011
2795It was their first annual meeting. Board members get paid a lot of money for trkrw36/15/2011
2794I've never attended an annual meeting before, and except for the audience quJeffry K. Smith-6/15/2011
2793Their first annual meeting was much more entertaining. An elderly fellow chewed rkrw-6/15/2011
2792GREAT summary! I attended the meeting also, but in no way could I have written Jeffry K. Smith-6/15/2011
2791Notes from Annual Meeting: I. Formal part of the meeting. Lasted about 15 minutRocky946/15/2011
2790New survey: <b>When will FDA approve first biosimilar/biogeneric?</b>DewDiligence_on_SI-6/15/2011
2789More color on the FDA's current thinking regarding biosimilars (hat tip to jtuck15/15/2011
2788say on pay vote in the proxy this year; and big raises for the execs, will be inmopgcw-5/14/2011
2787MNTA reports before market open on may 5th. Meanwhile, a technical breakout seetuck-4/25/2011
2786<b>MNTA ‘ReadMeFirst’ updated:</b> <i>NVS reports $247M (!) DewDiligence_on_SI-4/25/2011
2785According to NVS Earnings release, Enox sales of $247M this quarter. MNTA gets pgo-neil-4/19/2011
2784 By Brent Kendall and Alicia Mundy WASHINGTON (Dow Jones)--A chemist at theIan@SI-3/30/2011
2783reuters.comArthur Radley-3/29/2011
2782Actually I went to your values board to see if that gem had been reproduced thertom pope-3/26/2011
2781siliconinvestor.com So much for the <i>oracle</i>, LOL.DewDiligence_on_SI-3/26/2011
2780From the oracle - <i>Cramer said that Momenta Pharmaceuticals (MNTA_) hastom pope-3/26/2011
2779As long as the probability of a preliminary injunction is something greater thanDewDiligence_on_SI-3/7/2011
2778Quite honestly, I can draw no reasonable inference from this discovery date to aBiomaven-3/7/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News